体外肺モデルの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年～2030年、予測

体外肺モデル市場の世界需要は、調査期間2023年～2030年のCAGR18.29%で、2022年の3億3,666万米ドルから2030年には12億9,054万米ドル近くの市場規模に達すると推定されます。

体外肺モデルとは、研究、医薬品開発、試験を目的として生体外で作成されたヒト肺の人工的な表現またはシミュレーションです。これらのモデルは、呼吸生理学、疾患、薬物反応、毒物学を研究するために、肺の構造と機能の特定の側面を再現します。

市場力学

体外肺モデル市場の成長は、喘息やCOPDのような呼吸器疾患の有病率の増加によって促進されており、信頼性の高い研究モデルが必要とされています。体外肺モデルは、疾患メカニズム、薬物反応、潜在的な治療法を研究するための制御された環境を提供し、効果的なソリューションに対する需要の高まりに対応しています。製薬業界は、呼吸器疾患に対する薬剤開発と試験を迅速化し、動物実験への依存を減らし、薬剤相互作用と毒性の評価を合理化するために、これらのモデルに大きく依存しています。さらに、個別化医療が普及するにつれて、体外肺モデルは治療に対する個々の患者の反応を予測するのに不可欠であり、標的療法の開発に役立っています。組織工学や3Dプリンティングを含む技術の進歩は、これらのモデルの精度と精巧さを向上させ、実際の肺組織や肺機能との類似性を高めています。さらに、動物実験を減らす規制上の圧力と吸入毒性研究の進歩が、体外肺モデルの採用をさらに後押ししています。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは体外肺モデルの世界市場における各セグメントを包括的に評価することもできます。体外肺モデル産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける体外肺モデル市場の現在および将来の需要を強調する地域展望をカバーします。さらに、このレポートでは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

• 市場のハイライト
• 世界市場スナップショット

第3章 体外肺モデル - 産業分析

• イントロダクション：市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 産業動向
• ポーターのファイブフォース分析
• 市場魅力度分析

第4章 バリューチェーン分析

• バリューチェーン分析
• 原材料分析
  • 原材料リスト
  • 原材料メーカーリスト
  • 主要原材料の価格動向
• 潜在的バイヤーのリスト
• マーケティングチャネル
  • ダイレクトマーケティング
  • インダイレクトマーケティング
  • マーケティングチャネル発展動向

第5章 体外肺モデルの世界市場分析：タイプ別

• タイプ別概要
• 実績データと予測データ
• タイプ別分析
• 2Dモデル
• 3Dモデル

第6章 体外肺モデルの世界市場分析：用途別

• 概要：用途別
• 実績データと予測データ
• 分析：用途別
• 創薬・毒性研究
• 生理学研究
• 3Dモデル開発
• その他

第7章 体外肺モデルの世界市場分析：最終用途別

• 最終用途別概要
• 実績データと予測データ
• 最終用途別分析
• 学術研究機関
• 製薬・バイオテクノロジー企業
• その他

第8章 体外肺モデルの世界市場分析：地域別

• 地域別展望
• イントロダクション
• 北米売上分析
  • 概要、実績と予測
  • 北米：セグメント別
  • 北米：国別
  • 米国
  • カナダ
  • メキシコ
• 欧州売上分析
  • 概要、実績と予測
  • 欧州：セグメント別
  • 欧州：国別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • その他の欧州
• アジア太平洋売上分析
  • 概要、実績と予測
  • アジア太平洋：セグメント別
  • アジア太平洋：国別
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • 東南アジア
  • その他のアジア太平洋
• ラテンアメリカ売上分析
  • 概要、実績と予測
  • ラテンアメリカ：セグメント別
  • ラテンアメリカ：国別
  • ブラジル
  • アルゼンチン
  • ペルー
  • チリ
  • その他のラテンアメリカ
• 中東・アフリカ売上分析
  • 概要、実績と予測
  • 中東・アフリカ：セグメント別
  • 中東・アフリカ：国別売上分析
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他の中東・アフリカ

第9章 体外肺モデル企業の競合情勢

• 体外肺モデル市場の競合
• 提携・協力・協定
• 合併・買収
• 新製品の上市
• その他の開発

第10章 企業プロファイル

• 企業シェア分析
• 市場集中度
• Epithelix
• MATTEK
• Lonza
• Emulate
• AlveoliX AG
• Nortis
• CN Bio Innovations Ltd
• MIMETAS
• InSphero
• ATTC Global

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Type (USD MN)
• 2D Model Market Sales by Geography (USD MN)
• 3D Model Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Drug Discovery & Toxicology Studies Market Sales by Geography (USD MN)
• Physiological Research Market Sales by Geography (USD MN)
• 3D Model Development Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-use (USD MN)
• Academic Research Institutes Market Sales by Geography (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global In Vitro Lung Model Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of In Vitro Lung Model Report
• Market Research Process
• Market Research Methodology
• Global In Vitro Lung Model Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Type
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Type (USD MN)
• 2D Model Market Sales by Geography (USD MN)
• 3D Model Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Drug Discovery & Toxicology Studies Market Sales by Geography (USD MN)
• Physiological Research Market Sales by Geography (USD MN)
• 3D Model Development Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Academic Research Institutes Market Sales by Geography (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

The global demand for In Vitro Lung Model Market is presumed to reach the market size of nearly USD 1290.54 MN by 2030 from USD 336.66 MN in 2022 with a CAGR of 18.29% under the study period 2023 - 2030.

An in vitro lung model is an artificial representation or simulation of the human lung created for research, drug development, and testing purposes outside of a living organism. These models replicate certain aspects of lung structure and function to study respiratory physiology, diseases, drug responses, and toxicology.

MARKET DYNAMICS

The in vitro lung model market growth is fueled by the increasing prevalence of respiratory diseases like asthma and COPD, which necessitates reliable research models. In vitro lung models provide a controlled environment to study disease mechanisms, drug responses, and potential treatments, catering to the rising demand for effective solutions. Pharmaceutical industries heavily rely on these models to expedite drug development and testing for respiratory conditions, reducing reliance on animal testing and streamlining the assessment of drug interactions and toxicity. Additionally, as personalized medicine gains traction, in vitro lung models are vital in predicting individual patient responses to treatments, aiding in the development of targeted therapies. Technological advancements, including tissue engineering and 3D printing, enhance the accuracy and sophistication of these models, augmenting their resemblance to actual lung tissue and function. Moreover, regulatory pressures to reduce animal testing and advancements in inhalation toxicology studies further drive the adoption of in vitro lung models.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in vitro lung model. The growth and trends of in vitro lung model industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the in vitro lung model market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• 2D Model
• 3D Model

By Application

• Drug Discovery & Toxicology Studies
• Physiological Research
• 3D Model Development
• Others

By End-Use

• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the In Vitro Lung Model market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In Vitro Lung Model market include Epithelix, MATTEK, Lonza, Emulate, AlveoliX AG, Nortis, CN Bio Innovations Ltd, MIMETAS, InSphero, ATTC Global. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . IN VITRO LUNG MODEL - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY TYPE

• 5.1 Overview by Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Type
• 5.4 2D Model Historic and Forecast Sales by Regions
• 5.5 3D Model Historic and Forecast Sales by Regions

6 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Drug Discovery & Toxicology Studies Historic and Forecast Sales by Regions
• 6.5 Physiological Research Historic and Forecast Sales by Regions
• 6.6 3D Model Development Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY END-USE

• 7.1 Overview by End-use
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-use
• 7.4 Academic Research Institutes Historic and Forecast Sales by Regions
• 7.5 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
• 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE IN VITRO LUNG MODEL COMPANIES

• 9.1. In Vitro Lung Model Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF IN VITRO LUNG MODEL INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Epithelix
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. MATTEK
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Lonza
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Emulate
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. AlveoliX AG
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Nortis
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. CN Bio Innovations Ltd
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. MIMETAS
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. InSphero
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. ATTC Global
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies